The Cassava Cassava Sciences - Unofficial - Investors $SAVA biotech company developing simufilam for Alzheimer is featured among the most highly shorted stocks, and by some estimates, over $100 million has been made from short selling this single stock Elizabeth McNally Journal of Clinical Investigation
jci.org/articles/view/…

MagnificentAnswer Lindsay B Cassava Sciences - Unofficial - Investors I think some sort of retraction would have been better than a silent deletion. Think of the people that read everything Patrick Radden Keefe writes
$sava

Which Door would you Enter🤔
Blue or Red

#ENDALZ #CareGiving #Father #Hope #Mother #CareGiver #Simufilam #CassavaSciences #Alzhiemers #FDA #EndAlzhiemers #EndOfLife
#AlzheimerPatients $SAVA #IBelieveInSimufilam #dementia

Remarkable. Need to pursue invitro with #Simufilam for #TNBC with and without #pembrolizumab #Keytruda
#kkillian
$SAVA
#CassavaSciences

frontiersin.org/articles/10.33…

$SAVA Cassava Sciences - Unofficial - Investors #Alzheimers #endalzheimers Alzheimer's Association Alzheimer's Society

Elisabeth Bik is in New York Truthful Hand - COVID shouldn’t be here at all !! Joe Springer Cassava Sciences - Unofficial - Investors Alzheimer Society of Canada AlzheimersResearchUK 🍊 UsAgainstAlzheimer's AARP Foundation AARP Advocates AARP Policy AARP California AARP International Most $SAVA longs are investors who have/had loved ones with AD. Why should you so concerned about ppl signing the petition to provide disclosure? The world needs AD drugs now to save life, reduce caregiver care & tax payers money.

Cassava Sciences - Unofficial - Investors So, any news?

$SAVA CassavaSciences 2023 catalysts:
1)CMS dosing finished JUN
2)Ph.3 RETHINK fully enrolled JUL
3)CMS data readout JUL-AUG
4)Ph.3 REFOCUS fully enrolled SEP
5) Indep. 3rd Party Presents Evidential Data for The Biological Activity of Simufilam Outside of Neurodegeneration Q2-Q3

IMHO, 5/15/23 “Frontiers In Neurology” article highlights importance of #CassavaSciences ’ (often overlooked) Blood Brain Barrier (BBB) biomarker improvements. May bolster #simufilam ’s MoA and lead to add'l positive $SAVA developments beyond its safe and very promising #ALZ drug.

#Simufilam dosing for textbook (U.S. FDA designed) placebo controlled, Enriched/Randomized Withdrawal trial for #ALZ is complete. IMHO Phase 2 can now be considered complete (based on #CassavaSciences Slide 20 & Pg 9 of $SAVA's latest 10K). Full Approval next? My reasoning below:

cave bear Elisabeth Bik Truthful Hand - COVID shouldn’t be here at all !! Joe Springer Cassava Sciences - Unofficial - Investors Alzheimer Society of Canada AlzheimersResearchUK 🍊 UsAgainstAlzheimer's AARP Foundation AARP Advocates AARP Policy AARP California AARP International Elisabeth Bik - just doubling up here, since you failed to respond.

$SAVA #ENDALZ

Over 1,244 Alzheimer’s patients now enrolled in Phase 3 studies of simufilam.

Completion of patient enrollment for Phase 3 program still expected Q4 2023.

$187.5 Million Cash and Cash Equivalents at March 31, 2023.

cassavasciences.com/static-files/f…

FDA reviewers say Sarepta’s DMD gene therapy hasn’t shown “unambiguous evidence” that it’s “likely beneficial for ambulatory patients with DMD,” raises safety concerns related to a “possibly ineffective gene therapy.” But also notes urgent medical need: fda.gov/media/168021/d…

Cassava Sciences - Unofficial - Investors That’s great but why n=2 reading only. When is the complete data set

Cassava Sciences - Unofficial - Investors Yale study also showed/confirmed Simufilam biological activities with FLNA.

External validation.

Don’t let weeds rob next year’s crop of nutrients and moisture - destroy them at harvest! 🌾

Redekop’s seed control unit (SCU) kills up to 98% of harvestable weeds in a single pass with ZERO chemicals! 🙌

Order yours today, so it’s on your farm this harvest!

Elisabeth Bik is in New York Truthful Hand - COVID shouldn’t be here at all !! Joe Springer Cassava Sciences - Unofficial - Investors Alzheimer Society of Canada AlzheimersResearchUK 🍊 UsAgainstAlzheimer's AARP Foundation AARP Advocates AARP Policy AARP California AARP International Wait, what? When was that, Dr. B?

stephen Archisaurus YMB Cassava Sciences - Unofficial - Investors U.S. FDA Matt Nachtrab Matthew Yaroch Ⓜ️ Alzheimer's Association Alzheimer Society of Canada Cure Alzheimer's Fund Alzheimer's Los Angeles Alzheimer's Society Lindsay B Here is your answer!! Pretty impressive 😳 $SAVA

If you want to strengthen your brain, read this (scientifically proven):

MagnificentAnswer Lindsay B Cassava Sciences - Unofficial - Investors Patrick Radden Keefe The New York Times didn't just silently *try* to cover-up their misstatements about Dr David Bredt's employment status at MPM Capital. imo The New Yorker and their contributors could learn a thing or two

Which Door would you Enter🤔
Meg Tirrell
Elon Musk
CNN
Blue or Red #ENDALZ #CareGiving #Father #Hope #Mother #CareGiver #Simufilam #CassavaSciences #Alzhiemers #FDA #EndAlzhiemers #EndOfLife #AlzheimerPatients $SAVA #IBelieveInSimufilam #dementia

Did you know that Catalent’s lozenges are crafted in small batches with naturally sourced flavors and only the finest ingredients of your choice? Looking for a new format, check out the technical advantages and consumer benefits of lozenges.

$SAVA

New Data by Academic Researchers Highlights Biological Activity of Simufilam on Filamin A.

Data to be presented at the European Society of Endocrinology, May 13-16th.

cassavasciences.com/node/16366/pdf

$SAVA

Cassava Sciences Completes Patient Dosing in a Randomized Controlled Trial of Simufilam in Alzheimer’s Disease

cassavasciences.com/node/16406/pdf